MOG antibody-associated disease – a new entity or one of the forms of the NMO spectrum?
Myelin oligodendrocyte glycoprotein (MOG) is a protein involved in the maintenance of the myelin structure. Recent studies have shown that serum anti-MOG antibodies are found in some of the patients who meet the diagnostic criteria for neuromyelitis optica spectrum disorders, but do not have detecta...
Main Authors: | Dominika Czarnecka, Mariusz Stasiołek |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Communications Sp. z o.o.
2019-10-01
|
Series: | Aktualności Neurologiczne |
Subjects: | |
Online Access: | http://neurologia.com.pl/index.php/issues/2019-vol-19-no-3/mog-antibody-associated-disease-a-new-entity-or-one-of-the-forms-of-the-nmo-spectrum?aid=1058 |
Similar Items
-
Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents
by: Renata Barbosa Paolilo, et al.
Published: (2023-02-01) -
Clinical and Radiological Characteristics of Patients with Anti-Aquaporin 4 and Anti-Myelin Oligodentrocyte Glycoprotein Antibody-Associated Neuromyelitis Optica Spectrum Disease
by: Melike Doğan Ünlü, et al.
Published: (2024-04-01) -
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Optic Neuritis – A Case Report and Literature Review
by: Nowacka B, et al.
Published: (2024-04-01) -
Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review
by: Michela Ada Noris Ferilli, et al.
Published: (2021-12-01) -
Features of the diagnosis and treatment of patients with AQP-4-positive neuromyelitis optica and MOG antibody disease
by: V. E. Avdeeva, et al.
Published: (2021-11-01)